D-0497-2023 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0497-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: 16 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2023
Initiation Date
Mar 20, 2023
Termination Date
Oct 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16 bottles

Product description

Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00

Reason for recall

cGMP Deviations

Distribution pattern

RemedyRepack distributed product to consignees nationwide within the United States

Code information

Lot #: B1635780-040522, Exp. Date 04/30/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0497-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0497-2023. Report a data issue: hello@regdatalab.com.